Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NORDEN Raises Expectations for the Full-Year Result 2022

ANNOUNCEMENT NO. 143 - 4 AUGUST 2022   NORDEN raises its expectations for the full-year result, and now expects profit for 2022 in the range of USD 560-640 million (approximately DKK 4,100-4,700 million), up from USD 420-500 million.   In line with NORDEN’s shift in market exposure from dry cargo to product tankers during Q2, the Company has been well positioned to capitalise on a weakening dry cargo market having booked more cargo than tonnage. NORDEN also continues to benefit from an exceptionally strong product tanker market, where the Company has significant market exposure.

Company announcement no. 85, 2022 - Auctions of covered mortgage bonds in Nordea Kredit Realkreditaktieselskab.

The refinancing of Nordea Kredit ARMs with annual refinancing on 1 October 2022 will be conducted via auctions of covered mortgage bonds (SDRO). The covered mortgage bonds are rated AAA by Standard & Poor´s.   The auctions will be performed by Nordea Bank Abp and will be held at either the NASDAQ Copenhagen auction market or Bloomberg AUPD on Wednesday, 24 August and Thursday, 25 August 2022.   The auctions will open daily at 9.30 a.m. and close either by 10.30 a.m., 11.15 a.m. or 11.45 a.m.. Investors will be notified of accepted bids as soon as possible after the closing of

Sollentuna Stinsen JV AB – Approval of written procedure and amendments to the terms and conditions of the bonds

Sollentuna Stinsen JV AB (the "Company") today announces the successful completion of the written procedure that was initiated 15 July 2022 in relation to the Company's outstanding up to SEK 500,000,000 senior secured bond loan 2019/2022 with ISIN SE0013122058 (the "Bonds"), regarding certain amendments to the terms and conditions of the Bonds (the "Proposal"). A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of the bondholders voted in favour to approve the Proposal. The amendments in accordance with the

Photocure ASA: Invitation to presentation of second quarter and first half year 2022 financial results

Oslo, Norway, 4 August 2022: Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2022 financial results on Wednesday 10 August 2022 at 08:00 CEST and invites investors, analysts and the media to a presentation at Hotel Continental, Oslo, Norway at 14:00 CEST the same day.The investor presentation will also be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45 CEST. The quarterly

Eco Wave Power Commences Real Conditions Test Runs of its Newest EWP-EDF One Wave Energy Project at Jaffa Port, Israel

Landmark installation located at the Port of Jaffa in Tel Aviv will be the first wave-powered energy station connected to Israel’s energy grid. TEL AVIV, ISRAEL (August 4, 2022) –– Eco Wave Power Global AB (publ) (Nasdaq Capital Market: WAVE) (“Eco Wave Power” or the “Company”) announced today that it has officially commenced test runs of its newly installed wave energy pilot project at the Port of Jaffa in Tel Aviv, Israel. The EWP-EDF One project is executed in collaboration and co-funding from EDF Renewables IL and the Israeli Energy Ministry, which recognized the Eco Wave

Exel Composites Plc: Announcement regarding change in shareholdings

EXEL COMPOSITES PLC    STOCK EXCHANGE RELEASE    4 AUGUST 2022 at 16:00 EETExel Composites Plc has on 4 August 2022 received a disclosure under Chapter 9, Section 5 of the Finnish Securities Markets Act according to which the holding of Swedbank Robur Fonder investment fund has decreased below 5% of the voting rights and share capital in Exel Composites Plc.   After the share transactions concluded on 3 August 2022, the holding of Swedbank Robur Fonder AB amounts to 560,000 shares representing 4.71% of the shares and voting rights of the Company. The earlier holding of Swedbank Robur

AcouSort’s and Werfen’s joint patent application has received national approval in the US

AcouSort AB (publ) (“AcouSort”, the “Company”) today announces that the Company's and its partner Werfen’s ("Werfen") (formerly Instrumentation Laboratory Company) U.S. patent application received national approval in the United States on August 3, 2022. According to PCT regulations, the original international application was published in the database after April 7, 2018. The patent application concerns an acoustofluidics technology that separates blood plasma from whole blood and enables analysis of the plasma using either optical or electrical methods. The technology to which the patent

Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®

Oslo, 4 August 2022 - Navamedic has signed an agreement with the French pharmaceutical company Vectans Pharma, which gives Navamedic the exclusive right to market and sell an innovative and unique muco-adhesive buccal tablet for single-dose treatment of cold sores (herpes labialis) in the Nordic and Benelux regions. This entitles Navamedic to the ownership of the marketing authorizations for the product in these regions.   “This acquisition is a great example of how we can utilize our strong presence and in-depth competence in our markets to broaden our portfolio through partnerships

Qt Group Plc: Half-Year Report January-June 2022

Qt Group Plc, stock exchange release, August 4, 2022 at 3:00 pm EESTThis release is a summary of Qt Group Plc’s Half-Year Report January-June 2022. The complete report is attached to this release as a PDF file, and it is also available on the company's website at www.qt.io/investors Second quarter 2022: General economic uncertainty impacted revenue growth more than expected,  good outlook for the rest of the year April – June 2022 · Net sales increased 9.3 percent to EUR 37,090 thousand (EUR 33,925 thousand). The effect of exchange rates on the comparison period’s net sales was

Correction to Enersense’s Half-year Financial Report published on 4 August 2022

Enersense International PlcStock exchange release 4 August 2022 at 2:35 p.m.Market value of the share capital shown in the key figures per share table on page 19 on 30.6.2022 in the Half-year Financial Report published by Enersense on 4 August 2022 was incorrect. The corrected table is below: Key figures per share [] 30.6.2022 30.6.2021 31.12.2021Market             123,829,513            139,336,382               91,640,466value,EURNumber of

Relais will publish its Half-Year Financial Report January-June 2022 on 11 August 2022 at 9:00 a.m. EET, webcast at 10:00 a.m.

Relais Group PlcPress Release 4 August 2022 at 2:00 p.m. EET Relais Group Plc will publish its Half-Year Financial Report January-June 2022 on Thursday, 11 August 2022 at 9:00 a.m. EET and it will be available after publishing on the company's website at https://relais.fi/en/investors/. Relais Group will arrange a webcast for analysts, investors and media on 11 August 2022, at 10:00 a.m. EET. The webcast will be held in English. Relais Group’s CEO Arni Ekholm and CFO Pekka Raatikainen will host the event. The webcast can be followed at https://relais.videosync.fi/2022-q2-results.

Genovis AB enters service agreement with evitria AG for fast LC-MS analysis of recombinant antibodies

Genovis AB and evitria AG today signed a service agreement to offer evitria’s customers fast LC-MS characterization of recombinant antibodies using Genovis proprietary enzyme technologies. evitria AG is a world leading service provider for recombinant antibody expression in CHO cells with headquarters in Zürich, Switzerland.With this new service agreement, Genovis expands into a new business area that combines the ease of use of the SmartEnzymes[TM] with the competence and experience in the Genovis team to make advanced LC-MS analytics of recombinant antibodies available to a broader market.

AutoStore: Invitation to presentation of the second quarter and first half 2022 financial results

(Nedre Vats, 4 August 2022): AutoStore Holdings Ltd (AutoStore: OSE:AUTO) invites investors, analysts and journalists to join the presentation of the second quarter and first half results of 2022 on Thursday 18 August 2022 at 08:00 CEST.Reporting day program (CEST):   06:00 - Announcement of the second quarter and first half 2022 financial results. All material will be made available on newsweb.no and www.autostoresystem.com. 08:00 - Presentation at Høyres Hus, Oslo. The presentation will be hosted by Karl Johan Lier, CEO, Bent Skisaker, CFO, and Mats Hovland Vikse, CRO. The

Prostatype Genomics AB announces last day of trading in BTU and first day of trading in warrants of series TO 2

Prostatype Genomics AB’s (“Prostatype Genomics” or the “Company”) rights issue of units, for which the subscription period ended on 20 July 2022, has now been registered with the Swedish Companies Registration Office. The Company hereby announces that the last day of trading in paid subscribed units (Sw. BTU) will be on 10 August 2022 and stop day will be on 12 August 2022. First day of trading in warrants of series TO 2 is 16 August 2022.In July 2022, Prostatype Genomics conducted a rights issue of units, which provided the Company with approximately SEK 22.5 million before deduction of

Quickbit acquires two B2B product platforms – enabling increased profitability and growth

Through the acquisition, Quickbit gets access to two platforms with complementary products in Quickbit's B2B offer. The purchase includes full IP rights and gives access to a new customer database containing merchants. The purchase price amounts to 4.5 mEUR and is financed in its entirety with own cash and is expected to contribute to Quickbit's revenue and result in Q2 '22/23. The acquisition agreement has been entered into with Parman Enterprises UK Limited.The products will provide access to a new customer database containing merchants and will simplify the checkout process for both

Enersense International Plc's January-June 2022 Half-year Financial Report:

Enersense Internatonal PlcStock exchange release 4 August 2022 at 12:30 p.m.The challenging business environment burdened the result for the first half of the year – The company is preparing for the green transition through significant investmentsThis release is a summary of Enersense's 2022 Half-year Financial Report. The complete report is attached to this release as a pdf-file. It is also available on the company's website at www.enersense.com/investors. April–June 2022 •    Revenue EUR 59.8 million (61.6), -2,9% year-on-year •    EBITDA EUR -0.6 million (5.8), EBITDA margin

Pro VC awarded a National Teaching Fellowship

Staffordshire University’s new Pro Vice-Chancellor has been recognised with a National Teaching Fellowship for his ground-breaking work on degree apprenticeships.Professor Raheel Nawaz has recently joined Staffordshire University from Manchester Metropolitan University where he headed up their Digital Degree Apprenticeships portfolio and founded the Apprenticeships Research Unit. He is one of 54 new National Teaching fellows announced by Advance HE which celebrates and recognises individuals who have made an outstanding impact on student outcomes and the teaching profession in higher

Invitation to news conference: Kamux Corporation publishes its Half Year Financial Report for January–June on August 12, 2022

Kamux Corporation Press release 4.8.2022 at 12:00 Invitation to news conference: Kamux Corporation publishes its Half Year Financial Report for January–June on August 12, 2022 Kamux Corporation will publish its Half Year Financial Report for January–June 2022 on Friday, August 12, 2022 at approximately 9:00 EET. The report will be available at www.kamux.com after publishing. News conference for investors, analysts and media will be held on Friday, August 12, 2022 at Sanomatalo, Flik Studio Eliel, 1[st] floor, Töölönlahdenkatu 2, Helsinki at 11:00 EET in English, and at 12:00 noon

Arié and Europi acquire Lx Factory in Lisbon, from a fund managed by Keys REIM

Lx Factory has been acquired by a joint venture between the Arié Group and Europi Property Group, in an investment process managed by Bedrock Capital, for an undisclosed amount. The vendor, a fund managed by Keys REIM a French asset manager, has owned and managed Lx Factory since 2017. Arié, Europi and Bedrock intend to preserve Lx Factory’s unique identity and cultural heritage, which shall continue its mixed-use offering of office, retail and F&B while maintaining its iconic industrial look & feel. Plans are being drawn up to renovate existing spaces as well as improve the public realm

Inhalation Sciences receives landmark FDA approval for co-financing of its study to validate DissolvIt as a standard research method in the US

(Stockholm, 4 August 2022) The US FDA (Food and Drug Administration) has approved Inhalation Sciences’ proposal for a research study aiming to validate the company’s in vitro lung simulation model DissolvIt[®] as an FDA-recommended dissolution technology, and ultimately a new ‘golden standard’ for dissolution testing for inhaled drugs. The FDA will support and co-finance the study with up to 250 000 USD annually for up to two years. The study will commence in the coming months.The US FDA’s National Center for Toxicological Research has approved ISAB’s research proposal for a study aiming to

BioStock: EU gene therapy approval positive for CombiGene

Recently, PTC Therapeutics was granted marketing authorisation by the European Commission for the gene therapy Upstaza for the treatment of a rare genetic disease. This is good news for Swedish CombiGene, whose gene therapy CG01 for the treatment of epilepsy, which was outlicensed to Spark Therapeutics in the autumn of 2021, like Upstaza, is intended to be administered directly into the brain of patients. BioStock reached out to CombiGene’s CEO Jan Nilsson for a comment.Read the full interview with Jan Nilsson at biostock.se: https://www.biostock.se/en/2022/08/eu-gene-therapy-approval-

HEAT-FIT: The fire-retardant pipe jacket system by GF Piping Systems receives DNV, BV, ABS, and LR approvals

HEAT-FIT is designed to bring lightweight, corrosion-free, and efficient thermoplastic piping systems to essential applications onboard ships. Now, the fire-retardant pipe jacket system has been approved by no less than four of the leading certification societies in the maritime sector, DNV, Bureau Veritas, ABS and Lloyds Register. As a result, GF Piping Systems offers complete solutions that can be implemented throughout the entire ship and make the maritime industry more sustainable.The greenhouse gas (GHG) strategy by the International Maritime Organization (IMO) is very clear: Compared

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 142 - 4 AUGUST 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 117/2022.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Interim Report Q2 2022 - Ayima Group AB

Highlights Q2 : Apr - Jun 2022 · Total Revenue for the quarter amounted to 36.6 MSEK (40.5), a decrease of >10% from the previous year · Gross Profit increased by 1% to 20.7 MSEK (20.4) · EBITDA was 1.0 MSEK (4.7), a 78% decrease from the previous year · Net Profit after tax for the period was -1.8 MSEK (1.6) · Earnings per share (EPS) was -0.25 (0.15) YTD : Jan - Jun 2022 · Total Revenue amounted to 73.1 MSEK (77.3), a decrease of >5% from the previous year · Gross Profit increased by 3% to 42.3 MSEK (40.9) · EBITDA was 3.5 MSEK (9.7), a 64% decrease from

There are no items matching the current filter
There are no more items matching the current filter
Back to top